Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic Neoplasia

Full text
St Laurent, Jessica D. [1, 2] ; Lin, Lawrence H. [3, 4] ; Owen, David M. [5] ; Maesta, Izildinha [6] ; Castaneda, Arnold [2] ; Hasselblatt, Kathleen T. [2] ; Goldstein, Donald P. [2] ; Horowitz, Neil S. [2] ; Berkowitz, Ross S. [2] ; Elias, Kevin M. [1, 2]
Total Authors: 10
[1] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, 75 Francis St, Boston, MA 02115 - USA
[2] Harvard Med Sch, New England Trophoblast Dis Ctr, Dana Farber Canc Inst, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Div Gynecol Onc, 75 Francis St, Boston, MA 02115 - USA
[3] Univ Sao Paulo, Trophoblast Dis Ctr, Med Sch, Sao Paulo - Brazil
[4] New York Univ Langone Hlth, Dept Pathol, New York, NY - USA
[5] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 - USA
[6] Sao Paulo State Univ UNESP, Sao Paulo State Univ, Clin Hosp Botucatu Med Sch, Botucatu Trophoblast Dis Ctr, Botucatu, SP - Brazil
Total Affiliations: 6
Document type: Journal article
Source: REPRODUCTIVE SCIENCES; v. 28, n. 11, p. 3200-3211, NOV 2021.
Web of Science Citations: 1

To investigate if differences in imprinting at tropho-microRNA (miRNA) genomic clusters can distinguish between pre-gestational trophoblastic neoplasia cases (pre-GTN) and benign complete hydatidiform mole (CHM) cases at the time of initial uterine evacuation. miRNA sequencing was performed on frozen tissue from 39 CHM cases including 9 GTN cases. DIO3, DLK1, RTL1, and MEG 3 mRNA levels were assessed by qRT-PCR. Protein abundance was assessed by Western blot for DIO3, DLK1, and RTL1. qRT-PCR and Western blot were performed for selenoproteins and markers of oxidative stress. Immunohistochemistry (IHC) was performed for DIO3 on an independent validation set of clinical samples (n = 42) and compared to normal placenta controls across gestational ages. Relative expression of the 14q32 miRNA cluster was lower in pre-GTN cases. There were no differences in protein abundance of DLK1 or RTL1. Notably, there was lower protein expression of DIO3 in pre-GTN cases (5-fold, p < 0.03). There were no differences in mRNA levels of DIO3, DLK1, RTL1 or MEG 3. mRNA levels were higher in all CHM cases compared to normal placenta. IHC showed syncytiotrophoblast-specific DIO3 immunostaining in benign CHM cases and normal placenta, while pre-GTN cases of CHM lacked DIO3 expression. We describe two new biomarkers of pre-GTN CHM cases: decreased 14q32 miRNA expression and loss of DIO3 expression by IHC. Differences in imprinting between benign CHM and pre-GTN cases may provide insight into the fundamental development of CHM. (AU)

FAPESP's process: 20/08830-6 - Elucidating the effect of epigenetic modifications of complete hydatidiform mole microRNA signalling and risk of malignization
Grantee:Izildinha Maestá
Support type: Regular Research Grants